Valneva to Present on Chikungunya at Multiple Scientific Conferences in Q4 2023
October 11, 2023 – Valneva, a leading vaccine developer, has announced that it will be presenting at several scientific conferences in the fourth quarter of 2023, focusing on the mosquito-borne disease Chikungunya. The presentations aim to raise awareness about the increasing global threat of Chikungunya and the need for better protection against it.
One of the conferences where Valneva will be actively involved is IDWeek, the annual meeting of the Infectious Diseases Society of America (IDSA). On October 14, 2023, Valneva will sponsor a panel entitled “Chikungunya is an Increasing Global Threat: The Need for Better Protection” in Boston, Massachusetts. The session will take place at 6:00 p.m. EDT and aims to shed light on the urgent need for improved prevention and treatment strategies for Chikungunya.
Valneva will also be participating in the American Society of Tropical Medicine and Hygiene (ASTMH) 2023 Annual Meeting in Chicago, Illinois. The company will give two presentations on Chikungunya, scheduled at 11:00 a.m. and 12:15 p.m. CDT respectively. These presentations will provide insights into the latest research and advancements in Chikungunya prevention and treatment.
In addition, Valneva will present a poster at the World Vaccine Congress Europe in Barcelona, Spain, from October 16-19, 2023. The poster, titled “Safety of Live Attenuated Vaccines in Immunocompromised Patients and Pregnant Women: A Systematic Review,” will highlight the safety considerations for Chikungunya vaccines in vulnerable populations.
Another significant event where Valneva will showcase its expertise on Chikungunya is the International Society of Vaccines Annual Congress, taking place in Lausanne, Switzerland, on October 24, 2023. Valneva’s presentation, scheduled for 9:45 a.m. CEST, will delve into important developments in Chikungunya research and its potential impact on global health.
Furthermore, Valneva will be present at the European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Copenhagen, Denmark, from November 12th to 15th, 2023. This event will provide an opportunity for Valneva to engage with key stakeholders in the healthcare industry and discuss the economic implications of Chikungunya prevention and treatment.
Valneva’s participation in these conferences reflects its commitment to combating the global threat of Chikungunya. By collaborating with scientific communities and sharing valuable insights, Valneva aims to contribute to the development of effective prevention and treatment strategies for Chikungunya, ultimately improving global health outcomes.
Disclaimer: This article is generated from the provided content and may not represent the most up-to-date information on Valneva’s activities.]
#Valneva #lectures #Chikungunya #conferences #USA #Europe